Randomized, Phase 3, Placebo-Controlled Double-Blind, Multicenter Trial of a One Time Intracoronary Administration of Ad5.hAC6 Gene Transfer for Patients With Reduced Left Ventricular Heart Failure

Trial Profile

Randomized, Phase 3, Placebo-Controlled Double-Blind, Multicenter Trial of a One Time Intracoronary Administration of Ad5.hAC6 Gene Transfer for Patients With Reduced Left Ventricular Heart Failure

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs RT 100 (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms FLOURISH
  • Sponsors Renova Therapeutics
  • Most Recent Events

    • 11 Jan 2018 According to a Renova Therapeutics media release, an overview of this trial will be presented at the Keystone Symposium on Heart Failure.
    • 14 Dec 2017 According to a Renova Therapeutics media release, this trial is expected to begin in Q1 2018.
    • 27 Nov 2017 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top